Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-53.88	-301.68	-196.05
Graham Fair Price	-41.96	0.40	0.70
PEG	2018.64	0.93	0.04
Price/Book	-10.79	6.35	7.12
Price/Cash Flow	116.09	-370.62	171.51
Prices/Earnings	-150.61	-60.69	-24.22
Price/Sales	-4.74	69.52	72.98
Price/FCF	116.09	-370.62	171.51
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	29.05	0.20	0.15
Operating Margin	64.05	-0.28	-0.79
ROA	64.53	-0.02	-0.05
ROE	-0.07	-0.03	64.40
ROIC	-0.06	-0.02	64.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	-0.13	-25.41
Dividends QOQ	-0.18	-0.06	65.65
EBIT QOQ	-5.75	0.67	-88.31
EPS QOQ	-5.52	0.65	-88.17
FCF QOQ	0.89	-1.40	56.87
Revenue QOQ	-0.52	-0.09	83.17
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	109.84	121.76	10.85
Days Sales Outstanding (DSO)	265.85	282.72	6.35
Inventory Turnover	0.82	0.74	-9.79
Debt/Capitalization	0.11	0.13	10.91
Quick Ratio	0.84	0.79	-6.55
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.54	0.53	-2.72
Cash	0.02	0.02	-16.68
Capex	< 0.005	< 0.005	45.08
Free Cash Flow	0.02	< 0.005	-59.84
Revenue	0.05	0.05	-8.90
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.12	1.04	-6.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.52	-5.31	-110.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating